de Mendoza, Carmen <br/><br/>
Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.  [electronic resource] 

 -  HIV clinical trials   
 - 163-71 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct0704-163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Atazanavir Sulfate<br/>Carbamates--therapeutic use<br/>Drug Resistance, Viral--genetics<br/>Female<br/>Follow-Up Studies<br/>Furans<br/>HIV--drug effects<br/>HIV Infections--blood<br/>HIV Protease Inhibitors--therapeutic use<br/>Humans<br/>Indinavir--adverse effects<br/>Lopinavir<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Mutation<br/>Oligopeptides--therapeutic use<br/>Pyridines--therapeutic use<br/>Pyrimidinones--therapeutic use<br/>RNA, Viral--blood<br/>Retrospective Studies<br/>Ritonavir--therapeutic use<br/>Salvage Therapy<br/>Saquinavir--therapeutic use<br/>Spain<br/>Sulfonamides--therapeutic use<br/>Treatment Outcome<br/>Viral Load